Recon: FDA approves GSK’s Boostrix to prevent whooping cough in infants; EU Commission targets Teva for alleged anticompetitive practices
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy